Table of Contents Executive Summary 1 Industry Overview of Heterozygous Familial Hypercholesterolemia Drug 1.1 Definition of Heterozygous Familial Hypercholesterolemia Drug 1.2 Heterozygous Familial Hypercholesterolemia Drug Segment by Type 1.2.1 Global Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Gemcabene Calcium 1.2.3 MGL-3196 1.2.4 ST-103 1.2.5 Others 1.3 Heterozygous Familial Hypercholesterolemia Drug Segment by Applications 1.3.1 Global Heterozygous Familial Hypercholesterolemia Drug Consumption Comparison by Applications (2014-2025) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Global Heterozygous Familial Hypercholesterolemia Drug Overall Market 1.4.1 Global Heterozygous Familial Hypercholesterolemia Drug Revenue (2014-2025) 1.4.2 Global Heterozygous Familial Hypercholesterolemia Drug Production (2014-2025) 1.4.3 North America Heterozygous Familial Hypercholesterolemia Drug Status and Prospect (2014-2025) 1.4.4 Europe Heterozygous Familial Hypercholesterolemia Drug Status and Prospect (2014-2025) 1.4.5 China Heterozygous Familial Hypercholesterolemia Drug Status and Prospect (2014-2025) 1.4.6 Japan Heterozygous Familial Hypercholesterolemia Drug Status and Prospect (2014-2025) 1.4.7 Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Status and Prospect (2014-2025) 1.4.8 India Heterozygous Familial Hypercholesterolemia Drug Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Heterozygous Familial Hypercholesterolemia Drug 2.3 Manufacturing Process Analysis of Heterozygous Familial Hypercholesterolemia Drug 2.4 Industry Chain Structure of Heterozygous Familial Hypercholesterolemia Drug 3 Development and Manufacturing Plants Analysis of Heterozygous Familial Hypercholesterolemia Drug 3.1 Capacity and Commercial Production Date 3.2 Global Heterozygous Familial Hypercholesterolemia Drug Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Heterozygous Familial Hypercholesterolemia Drug 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Heterozygous Familial Hypercholesterolemia Drug Production and Capacity Analysis 4.2 Heterozygous Familial Hypercholesterolemia Drug Revenue Analysis 4.3 Heterozygous Familial Hypercholesterolemia Drug Price Analysis 4.4 Market Concentration Degree 5 Heterozygous Familial Hypercholesterolemia Drug Regional Market Analysis 5.1 Heterozygous Familial Hypercholesterolemia Drug Production by Regions 5.1.1 Global Heterozygous Familial Hypercholesterolemia Drug Production by Regions 5.1.2 Global Heterozygous Familial Hypercholesterolemia Drug Revenue by Regions 5.2 Heterozygous Familial Hypercholesterolemia Drug Consumption by Regions 5.3 North America Heterozygous Familial Hypercholesterolemia Drug Market Analysis 5.3.1 North America Heterozygous Familial Hypercholesterolemia Drug Production 5.3.2 North America Heterozygous Familial Hypercholesterolemia Drug Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Heterozygous Familial Hypercholesterolemia Drug Import and Export 5.4 Europe Heterozygous Familial Hypercholesterolemia Drug Market Analysis 5.4.1 Europe Heterozygous Familial Hypercholesterolemia Drug Production 5.4.2 Europe Heterozygous Familial Hypercholesterolemia Drug Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Heterozygous Familial Hypercholesterolemia Drug Import and Export 5.5 China Heterozygous Familial Hypercholesterolemia Drug Market Analysis 5.5.1 China Heterozygous Familial Hypercholesterolemia Drug Production 5.5.2 China Heterozygous Familial Hypercholesterolemia Drug Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Heterozygous Familial Hypercholesterolemia Drug Import and Export 5.6 Japan Heterozygous Familial Hypercholesterolemia Drug Market Analysis 5.6.1 Japan Heterozygous Familial Hypercholesterolemia Drug Production 5.6.2 Japan Heterozygous Familial Hypercholesterolemia Drug Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Heterozygous Familial Hypercholesterolemia Drug Import and Export 5.7 Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Market Analysis 5.7.1 Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Production 5.7.2 Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Import and Export 5.8 India Heterozygous Familial Hypercholesterolemia Drug Market Analysis 5.8.1 India Heterozygous Familial Hypercholesterolemia Drug Production 5.8.2 India Heterozygous Familial Hypercholesterolemia Drug Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Heterozygous Familial Hypercholesterolemia Drug Import and Export 6 Heterozygous Familial Hypercholesterolemia Drug Segment Market Analysis (by Type) 6.1 Global Heterozygous Familial Hypercholesterolemia Drug Production by Type 6.2 Global Heterozygous Familial Hypercholesterolemia Drug Revenue by Type 6.3 Heterozygous Familial Hypercholesterolemia Drug Price by Type 7 Heterozygous Familial Hypercholesterolemia Drug Segment Market Analysis (by Application) 7.1 Global Heterozygous Familial Hypercholesterolemia Drug Consumption by Application 7.2 Global Heterozygous Familial Hypercholesterolemia Drug Consumption Market Share by Application (2014-2019) 8 Heterozygous Familial Hypercholesterolemia Drug Major Manufacturers Analysis 8.1 Daewoong Co Ltd 8.1.1 Daewoong Co Ltd Heterozygous Familial Hypercholesterolemia Drug Production Sites and Area Served 8.1.2 Daewoong Co Ltd Product Introduction, Application and Specification 8.1.3 Daewoong Co Ltd Heterozygous Familial Hypercholesterolemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Esperion Therapeutics Inc 8.2.1 Esperion Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production Sites and Area Served 8.2.2 Esperion Therapeutics Inc Product Introduction, Application and Specification 8.2.3 Esperion Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Gemphire Therapeutics Inc 8.3.1 Gemphire Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production Sites and Area Served 8.3.2 Gemphire Therapeutics Inc Product Introduction, Application and Specification 8.3.3 Gemphire Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Madrigal Pharmaceuticals Inc 8.4.1 Madrigal Pharmaceuticals Inc Heterozygous Familial Hypercholesterolemia Drug Production Sites and Area Served 8.4.2 Madrigal Pharmaceuticals Inc Product Introduction, Application and Specification 8.4.3 Madrigal Pharmaceuticals Inc Heterozygous Familial Hypercholesterolemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 9 Development Trend of Analysis of Heterozygous Familial Hypercholesterolemia Drug Market 9.1 Global Heterozygous Familial Hypercholesterolemia Drug Market Trend Analysis 9.1.1 Global Heterozygous Familial Hypercholesterolemia Drug Market Size (Volume and Value) Forecast 2019-2025 9.2 Heterozygous Familial Hypercholesterolemia Drug Regional Market Trend 9.2.1 North America Heterozygous Familial Hypercholesterolemia Drug Forecast 2019-2025 9.2.2 Europe Heterozygous Familial Hypercholesterolemia Drug Forecast 2019-2025 9.2.3 China Heterozygous Familial Hypercholesterolemia Drug Forecast 2019-2025 9.2.4 Japan Heterozygous Familial Hypercholesterolemia Drug Forecast 2019-2025 9.2.5 Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Forecast 2019-2025 9.2.6 India Heterozygous Familial Hypercholesterolemia Drug Forecast 2019-2025 9.3 Heterozygous Familial Hypercholesterolemia Drug Market Trend (Product Type) 9.4 Heterozygous Familial Hypercholesterolemia Drug Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Heterozygous Familial Hypercholesterolemia Drug Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Heterozygous Familial Hypercholesterolemia Drug Table Global Heterozygous Familial Hypercholesterolemia Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Heterozygous Familial Hypercholesterolemia Drug Production Market Share by Types in 2018 Figure Gemcabene Calcium Product Picture Figure MGL-3196 Product Picture Figure ST-103 Product Picture Figure Others Product Picture Table Global Heterozygous Familial Hypercholesterolemia Drug Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Heterozygous Familial Hypercholesterolemia Drug Consumption Market Share by Applications in 2018 Figure Clinic Figure Hospital Figure Others Figure Global Heterozygous Familial Hypercholesterolemia Drug Revenue (Million USD) (2014-2025) Figure Global Heterozygous Familial Hypercholesterolemia Drug Production (K Pcs) (2014-2025) Figure North America Heterozygous Familial Hypercholesterolemia Drug Market Size (Million USD) (2014-2025) Figure Europe Heterozygous Familial Hypercholesterolemia Drug Market Size (Million USD) (2014-2025) Figure China Heterozygous Familial Hypercholesterolemia Drug Market Size (Million USD) (2014-2025) Figure Japan Heterozygous Familial Hypercholesterolemia Drug Market Size (Million USD) (2014-2025) Figure Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Market Size (Million USD) (2014-2025) Figure India Heterozygous Familial Hypercholesterolemia Drug Market Size (Million USD) (2014-2025) Table Heterozygous Familial Hypercholesterolemia Drug Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Heterozygous Familial Hypercholesterolemia Drug in 2018 Figure Manufacturing Process Analysis of Heterozygous Familial Hypercholesterolemia Drug Figure Industry Chain Structure of Heterozygous Familial Hypercholesterolemia Drug Table Capacity and Commercial Production Date of Key Manufacturers Table Global Heterozygous Familial Hypercholesterolemia Drug Manufacturing Plants Distribution Table Heterozygous Familial Hypercholesterolemia Drug Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Heterozygous Familial Hypercholesterolemia Drug Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Heterozygous Familial Hypercholesterolemia Drug Production (K Pcs) of Major Manufacturers (2014-2019) Table Heterozygous Familial Hypercholesterolemia Drug Production Market Share of Major Manufacturers (2014-2019) Figure Heterozygous Familial Hypercholesterolemia Drug Production Share by Manufacturers in 2018 Table Heterozygous Familial Hypercholesterolemia Drug Revenue (Million US$) of Major Manufacturers (2014-2019) Table Heterozygous Familial Hypercholesterolemia Drug Revenue Market Share of Major Manufacturers (2014-2019) Figure Heterozygous Familial Hypercholesterolemia Drug Revenue Share by Manufacturers in 2018 Table Heterozygous Familial Hypercholesterolemia Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Heterozygous Familial Hypercholesterolemia Drug Production by Regions 2014-2019 (K Pcs) Table Global Heterozygous Familial Hypercholesterolemia Drug Production Market Share by Regions 2014-2019 Figure Global Heterozygous Familial Hypercholesterolemia Drug Production Market Share by Regions in 2018 Table Global Heterozygous Familial Hypercholesterolemia Drug Revenue by Regions 2014-2019 (Million USD) Table Global Heterozygous Familial Hypercholesterolemia Drug Revenue Market Share by Regions 2014-2019 Figure Global Heterozygous Familial Hypercholesterolemia Drug Revenue Market Share by Regions in 2018 Table Global Heterozygous Familial Hypercholesterolemia Drug Consumption by Regions 2014-2019 (K Pcs) Table Global Heterozygous Familial Hypercholesterolemia Drug Consumption Market Share by Regions 2014-2019 Figure North America Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure North America Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table North America Heterozygous Familial Hypercholesterolemia Drug Production, Consumption Import and Export (K Pcs) Figure Europe Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure Europe Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table Europe Heterozygous Familial Hypercholesterolemia Drug Production, Consumption Import and Export (K Pcs) Figure China Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure China Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table China Heterozygous Familial Hypercholesterolemia Drug Production, Consumption Import and Export (K Pcs) Figure Japan Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure Japan Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table Japan Heterozygous Familial Hypercholesterolemia Drug Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Production, Consumption Import and Export (K Pcs) Figure India Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure India Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table India Heterozygous Familial Hypercholesterolemia Drug Production, Consumption Import and Export (K Pcs) Figure Global Consumption Heterozygous Familial Hypercholesterolemia Drug Market Share by Application (2014-2019) Figure Global Value (Consumption) Heterozygous Familial Hypercholesterolemia Drug Market Share by Application (2014-2019) Table Daewoong Co Ltd Heterozygous Familial Hypercholesterolemia Drug Production Sites and Area Served Table Daewoong Co Ltd Heterozygous Familial Hypercholesterolemia Drug Product Introduction, Application and Specification Table Daewoong Co Ltd Heterozygous Familial Hypercholesterolemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Daewoong Co Ltd Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate (2014-2019) Table Daewoong Co Ltd Heterozygous Familial Hypercholesterolemia Drug Production Market Share (2014-2019) Figure Daewoong Co Ltd Heterozygous Familial Hypercholesterolemia Drug Revenue Market Share (2014-2019) Table Daewoong Co Ltd Heterozygous Familial Hypercholesterolemia Drug Main Business and Markets Served Table Esperion Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production Sites and Area Served Table Esperion Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Product Introduction, Application and Specification Table Esperion Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Esperion Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate (2014-2019) Table Esperion Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production Market Share (2014-2019) Figure Esperion Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Revenue Market Share (2014-2019) Table Esperion Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Main Business and Markets Served Table Gemphire Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production Sites and Area Served Table Gemphire Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Product Introduction, Application and Specification Table Gemphire Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Gemphire Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate (2014-2019) Table Gemphire Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Production Market Share (2014-2019) Figure Gemphire Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Revenue Market Share (2014-2019) Table Gemphire Therapeutics Inc Heterozygous Familial Hypercholesterolemia Drug Main Business and Markets Served Table Madrigal Pharmaceuticals Inc Heterozygous Familial Hypercholesterolemia Drug Production Sites and Area Served Table Madrigal Pharmaceuticals Inc Heterozygous Familial Hypercholesterolemia Drug Product Introduction, Application and Specification Table Madrigal Pharmaceuticals Inc Heterozygous Familial Hypercholesterolemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Madrigal Pharmaceuticals Inc Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate (2014-2019) Table Madrigal Pharmaceuticals Inc Heterozygous Familial Hypercholesterolemia Drug Production Market Share (2014-2019) Figure Madrigal Pharmaceuticals Inc Heterozygous Familial Hypercholesterolemia Drug Revenue Market Share (2014-2019) Table Madrigal Pharmaceuticals Inc Heterozygous Familial Hypercholesterolemia Drug Main Business and Markets Served Figure Global Heterozygous Familial Hypercholesterolemia Drug Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Heterozygous Familial Hypercholesterolemia Drug Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Heterozygous Familial Hypercholesterolemia Drug Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Heterozygous Familial Hypercholesterolemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Heterozygous Familial Hypercholesterolemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Heterozygous Familial Hypercholesterolemia Drug by Type (2019-2025) Table Global Consumption (K Pcs) of Heterozygous Familial Hypercholesterolemia Drug by Application (2019-2025) Table Heterozygous Familial Hypercholesterolemia Drug Distributors List Table Heterozygous Familial Hypercholesterolemia Drug Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Daewoong Co Ltd Esperion Therapeutics Inc Gemphire Therapeutics Inc Madrigal Pharmaceuticals Inc